About Robert Bloder
Robert Bloder is chief commercial officer at Ascendia Pharmaceutical Solutions. The company provides formulation, analytical and manufacturing services for pharmaceutical products. He leads sales, marketing and business development, as well as private placements and mergers and acquisitions. He is also a director of Ascendia Pharmaceuticals.
Earlier, Bloder was vice president of global business development at Apotex. He was a board member and vice president of business development at Aveva Drug Delivery Systems. There, he helped turn an Elan Pharmaceuticals research facility into a global drug delivery company. He co-founded ESP Pharma, now Protein Design Labs, and served as vice president of market development. At ESP, he helped fund the company and grow CARDENE IV. He also worked in sales and marketing at Parke-Davis, now Pfizer, where he helped launch Lipitor and other products. He is named on patent publication 20020111828 for pharmaceutical sales and distribution.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Robert Bloder in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Bloder works with at each company, as listed on that company's latest Form D.
